Carol Feghali-Bostwick to Disease Progression
This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Disease Progression.
Connection Strength
0.266
-
Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis. Front Immunol. 2020; 11:383.
Score: 0.131
-
Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum. 2009 Jul 15; 61(7):958-65.
Score: 0.063
-
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 May; 14(5):682-689.
Score: 0.027
-
miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Res Ther. 2016 07 05; 18(1):155.
Score: 0.025
-
Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol. 2013 Jun; 182(6):2391-406.
Score: 0.020